UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification

Clinical cancer research, 2021-02, Vol.27 (3), p.689-703

2021

Volltextzugriff (PDF)

Vaccine technologies: From whole organisms to rationally designed protein assemblies

Biochemical pharmacology, 2016-11, Vol.120, p.1-14

2016

Volltextzugriff (PDF)

Vaccine protection against Zika virus from Brazil

Nature (London), 2016-08, Vol.536 (7617), p.474-478

2016

Volltextzugriff (PDF)

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Nature (London), 2022-01, Vol.601 (7894), p.617-622

2022

Volltextzugriff (PDF)

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial

Vaccine, 2016-01, Vol.34 (3), p.313-319

2016

Volltextzugriff (PDF)

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

Nature communications, 2021-01, Vol.12 (1), p.372-372, Article 372

2021

Volltextzugriff (PDF)

Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults

Nature communications, 2023-03, Vol.14 (1), p.1138-13, Article 1138

2023

Volltextzugriff (PDF)

How protein-based COVID vaccines could change the pandemic

Nature (London), 2021-11, Vol.599 (7885), p.359-360

Dolgin, Elie

2021

Volltextzugriff (PDF)

Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial

The Lancet infectious diseases, 2017-08, Vol.17 (8), p.843-853

2017

Volltextzugriff (PDF)

PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity

Human vaccines & immunotherapeutics, 2016-04, Vol.12 (4), p.1056-1069

2016

Volltextzugriff (PDF)

COVID-19 Vaccine Frontrunners and Their Nanotechnology Design

ACS nano, 2020-10, Vol.14 (10), p.12522-12537

2020

Volltextzugriff (PDF)

Specific long‐term changes in anti‐SARS‐CoV‐2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines

Journal of medical virology, 2024-07, Vol.96 (7), p.e29793-n/a

2024

Volltextzugriff (PDF)

Engineering Antiviral Vaccines

ACS nano, 2020-10, Vol.14 (10), p.12370-12389

2020

Volltextzugriff (PDF)

Hydrogel‐Based Slow Release of a Receptor‐Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS‐CoV‐2

Advanced materials (Weinheim), 2021-12, Vol.33 (51), p.e2104362-n/a

2021

Volltextzugriff (PDF)

Developing a low-cost and accessible COVID-19 vaccine for global health

PLoS neglected tropical diseases, 2020-07, Vol.14 (7), p.e0008548

2020

Volltextzugriff (PDF)

Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)

Clinical cancer research, 2024-09, Vol.30 (18), p.4044-4054

2024

Volltextzugriff (PDF)

Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach

Scientific reports, 2017-08, Vol.7 (1), p.8285-12, Article 8285

2017

Volltextzugriff (PDF)

In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology

Scientific reports, 2021-01, Vol.11 (1), p.1249-1249, Article 1249

2021

Volltextzugriff (PDF)

Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma

Clinical cancer research, 2024-07, Vol.30 (13), p.2729-2742

2024

Volltextzugriff (PDF)

Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults

Vaccine, 2014-04, Vol.32 (19), p.2251-2259

2014

Volltextzugriff (PDF)

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines

Frontiers in immunology, 2021-06, Vol.12, p.696791-696791

2021

Volltextzugriff (PDF)

Preclinical and clinical development of a dengue recombinant subunit vaccine

Vaccine, 2015-12, Vol.33 (50), p.7126-7134

2015

Volltextzugriff (PDF)

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

The New England journal of medicine, 2016-09, Vol.375 (11), p.1019-1032

2016

Volltextzugriff (PDF)

Recombinant lactobacillus expressing G protein of spring viremia of carp virus (SVCV) combined with ORF81 protein of koi herpesvirus (KHV): A promising way to induce protective immunity against SVCV and KHV infection in cyprinid fish via oral vaccination

Vaccine, 2015-06, Vol.33 (27), p.3092-3099

2015

Volltextzugriff (PDF)

1 – 25 von 6.588

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieVeterinary Microbiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.211)
Mit Volltextzugriff
(5.747)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(5.798)
Life Sciences & Biomedicine
(5.348)
Animals
(3.941)
Humans
(3.160)
Immunology
(3.089)
Vaccines, Subunit - Immunology
(2.650)
Vaccines
(2.529)
Mice
(2.267)
Female
(2.009)
Microbiology
(1.368)
Proteins
(1.321)
Antigens
(1.313)
Medicine, Research & Experimental
(1.274)
Research & Experimental Medicine
(1.274)
Biological And Medical Sciences
(1.257)
Immunization
(1.187)
Vaccines, Subunit - Administration & Dosage
(1.176)
Vaccination
(1.099)
Mice, Inbred Balb C
(1.044)
Subunit Vaccine
(1.027)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.729)
Ingenta
(3.804)
EZB Electronic Journals Library
(2.993)
Elsevier ScienceDirect Journals Collection
(2.031)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.882)
Ovid SocietyJournals and Single Titles
(1.662)
IngentaConnect Journals
(1.618)
Publisher or Other Site
(942)
Wiley Blackwell Single Titles
(615)
Springer journals
(571)
Taylor & Francis Journals
(503)
Taylor & Francis
(479)
Taylor & Francis Online
(442)
Wiley Online Library
(380)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(368)
Nature Journals
(282)
Oxford journals
(199)
JSTOR
(184)
Nexis Uni
(166)
Oxford Journals 2020 Medicine
(155)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(953)
Plos One
(171)
Expert Review Of Vaccines
(158)
Frontiers In Immunology
(156)
Human Vaccines & Immunotherapeutics
(135)
Vaccines
(124)
The Journal Of Immunology
(115)
Infection And Immunity
(114)
The journal Of Immunology/the journal Of Immunology
(107)
Scientific Reports
(72)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification

Vaccine technologies: From whole organisms to rationally designed protein assemblies

Vaccine protection against Zika virus from Brazil

Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults

How protein-based COVID vaccines could change the pandemic

Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial

PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity

COVID-19 Vaccine Frontrunners and Their Nanotechnology Design

Specific long‐term changes in anti‐SARS‐CoV‐2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines

Engineering Antiviral Vaccines

Hydrogel‐Based Slow Release of a Receptor‐Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS‐CoV‐2

Developing a low-cost and accessible COVID-19 vaccine for global health

Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)

Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach

In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology

Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma

Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines

Preclinical and clinical development of a dengue recombinant subunit vaccine

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Recombinant lactobacillus expressing G protein of spring viremia of carp virus (SVCV) combined with ORF81 protein of koi herpesvirus (KHV): A promising way to induce protective immunity against SVCV and KHV infection in cyprinid fish via oral vaccination

Aktive Filter

Suchergebnisse filtern